Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9QNN

APH(2'')-IVa with a fragment

This is a non-PDB format compatible entry.
Summary for 9QNN
Entry DOI10.2210/pdb9qnn/pdb
Related9QMR
DescriptorAPH(2'')-Id, 3-piperidin-4-yl-1~{H}-pyrrolo[2,3-b]pyridine, DIMETHYL SULFOXIDE, ... (4 entities in total)
Functional Keywordsinhibitor, complex, enzyme, antibiotic
Biological sourceEnterococcus casseliflavus
Total number of polymer chains2
Total formula weight75472.94
Authors
Guichou, J.F.,Gelin, M.,Tomaszczyk, M.,Kowalewski, J.,Lionne, C. (deposition date: 2025-03-25, release date: 2026-02-11)
Primary citationKowalewski, J.,Deutscher, R.,Richardoz, M.,Tomaszczyk, M.,Gelin, M.,Labesse, G.,Hausch, F.,Wright, G.D.,Dunyach-Remy, C.,Guichou, J.F.,Lionne, C.
Fragment-based drug design of a bacterial kinase inhibitor capable of increasing the antibiotic sensitivity of clinical isolates.
Commun Chem, 8:417-417, 2025
Cited by
PubMed Abstract: According to the World Health Organization (WHO), antimicrobial resistance is a serious global health issue. Overcoming antibiotic resistance involves several strategies, including the inhibition of resistance mechanisms. Among the various resistance mechanisms, aminoglycoside phosphotransferases (APHs) catalyze the transfer of the γ-phosphate from a nucleotide donor to various aminoglycosides, leading to their inactivation. In this work, using a fragment-based drug design (FBDD) approach, we have identified and characterized a promising APH inhibitor capable of increasing the sensitivity of Pseudomonas aeruginosa and Staphylococcus aureus resistant to aminoglycosides. It is therefore a good candidate for the future development of APH inhibitors to be prescribed in combination with aminoglycosides. This molecule is a competitive inhibitor of adenosine 5'-triphosphate (ATP), the phosphate donor of APHs. Further studies are required to optimize this molecule to improve its specificity for APHs and its bioavailability in bacteria.
PubMed: 41310159
DOI: 10.1038/s42004-025-01795-6
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.65 Å)
Structure validation

248942

PDB entries from 2026-02-11

PDB statisticsPDBj update infoContact PDBjnumon